MondayJun 11, 2018 11:51 am

Xanthic Biopharma, Inc. (CSE: XTHC) Pursues Profitability in 2019 by Expanding Marketing of Cannabinoid-Infused Powders via Strategic Partners

xTHC produces cannabinoid-infused drink powders from a non-cannabis and non-hemp source using a patent-pending process Business model is to be a first-mover and expand into more U.S. states, with the focus now on the California market; goal is to reach broad-based retail channels, not only dispensaries Company is partnering with and is minority owner of Oregon-based Avitas CBD Water, LLC (now renamed Xanthic Beverages) Xanthic Biopharma, Inc. (CSE: XTHC), on its initial investor conference call, projected multi-million dollar revenue and profitability in 2019 as it grows. It is a manufacturer of CBD-infused drink powder from a non-cannabis and non-hemp, economically…

Continue Reading

FridayJun 08, 2018 1:43 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) and the US Senate Celebrate Hemp History Week

U.S. Senate declares ‘Hemp History Week’ from June 4-10 Pending legislation in U.S. Congress to remove restrictions on hemp cultivation Hemp cultivation operations underway in the U.S. and Canada for Global Hemp Group Forty-eight years after the Controlled Substances Act (CSA) of 1970 criminalized its use, hemp may finally be escaping from its stigma as an illegal substance. An omen of that impending legitimacy appeared on Tuesday, June 5, 2018, when the U.S. Senate approved a resolution declaring June 4-10 ‘Hemp History Week’. The resolution made note of "the growing economic potential of industrial hemp" as well as its "historical relevance," and…

Continue Reading

TuesdayJun 05, 2018 11:30 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expands Patent Portfolio, Announces Exercise of 450,000 Existing Warrants

LXRP, a drug delivery platform innovator, has been awarded two new patent grants in the U.S. and expects three more from Australia Company already has more than 40 patent awards or applications from 40 countries globally; it is preparing new patent application filings and predicts more patent awards this year LXRP received $63,000 from the exercise of 450,000 warrants previously granted to third parties Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is growing its patent portfolio with two more patent grants in the U.S., predicting three more from Australia, and it is currently preparing new patent application filings as it…

Continue Reading

MondayJun 04, 2018 2:23 pm

BLOCKStrain Technology Corp. (TSX.V: DNAX) Leverages Big Data to Secure Cannabis Pipeline

Blockchain-based genetic registration process provides verification security for growers and consumers alike Global cannabis market projected to reach $31.4 billion by 2021 WeedMD becomes first Canadian Licensed Producer to adopt BLOCKStrain’s technology As the legal cannabis market continues to develop, concerns about ensuring transparency and quality control for the growing number of medicinal and recreational drug products sold to consumers continue to drive a necessary breed of entrepreneurship required to legitimize the industry. BLOCKStrain Technology Corp. (TSX.V: DNAX) has emerged as an innovative leader in the quality control arena, releasing its proprietary supply chain management platform as a secure means…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977